• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性肢端黑色素瘤的窄切缘切除:是否可接受?

Narrow-Margin Excision for Invasive Acral Melanoma: Is It Acceptable?

作者信息

Ito Takamichi, Kaku-Ito Yumiko, Wada-Ohno Maiko, Furue Masutaka

机构信息

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

出版信息

J Clin Med. 2020 Jul 16;9(7):2266. doi: 10.3390/jcm9072266.

DOI:10.3390/jcm9072266
PMID:32708762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7408916/
Abstract

In this retrospective review of 100 patients with primary invasive acral melanoma, we examined whether narrow-margin excision is warranted for acral melanoma. Patients treated with surgical margins recommended by the National Comprehensive Cancer Network (R-group) were compared to those treated with narrow margins (N-group). A total of 65 patients underwent narrow-margin excision. Positive margin status or local recurrence rarely occurred regardless of the excision margins, whereas fatal events frequently occurred, particularly among the patients with T4 melanoma. The mortality rates of N- and R-group with T1-3 melanomas were similar (1.36 and 1.28 per 100 person-years, respectively). However, patients with T4 melanoma treated with narrow-margin excision had a higher mortality rate (11.44 vs. 5.03 per 100 person-years). Kaplan-Meier analyses showed a worse prognosis in the N-group ( = 0.045) but this group had thicker Breslow thickness (4.21 mm vs. 2.03 mm, = 0.0013). A multivariate analysis showed that Breslow thickness was an independent risk factor, but surgical margin was not a risk factor for melanoma-specific survival or disease-free survival. In conclusion, although we could not find a difference between the narrow-margin excision and recommended-margin excision in this study, we suggest following current recommendations of guidelines. Our study warrants the prospective collection of data on acral melanoma to better define the prognosis of this infrequent type of melanoma.

摘要

在这项对100例原发性肢端浸润性黑色素瘤患者的回顾性研究中,我们探讨了肢端黑色素瘤是否适合进行窄切缘切除。将按照美国国立综合癌症网络推荐的手术切缘进行治疗的患者(R组)与接受窄切缘治疗的患者(N组)进行比较。共有65例患者接受了窄切缘切除。无论切缘如何,切缘阳性状态或局部复发很少发生,而致命事件频繁发生,尤其是在T4期黑色素瘤患者中。T1-3期黑色素瘤的N组和R组死亡率相似(分别为每100人年1.36和1.28)。然而,接受窄切缘切除的T4期黑色素瘤患者死亡率更高(每100人年11.44对5.03)。Kaplan-Meier分析显示N组预后较差(=0.045),但该组Breslow厚度更厚(4.21mm对2.03mm,=0.0013)。多因素分析显示,Breslow厚度是独立危险因素,但手术切缘不是黑色素瘤特异性生存或无病生存的危险因素。总之,尽管在本研究中我们未发现窄切缘切除与推荐切缘切除之间存在差异,但我们建议遵循当前指南的建议。我们的研究需要前瞻性收集肢端黑色素瘤的数据,以更好地明确这种罕见类型黑色素瘤的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/a6f35bd3a482/jcm-09-02266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/c200bb68c483/jcm-09-02266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/c4b2a6440766/jcm-09-02266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/43c82ce8f2dd/jcm-09-02266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/a6f35bd3a482/jcm-09-02266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/c200bb68c483/jcm-09-02266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/c4b2a6440766/jcm-09-02266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/43c82ce8f2dd/jcm-09-02266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7b/7408916/a6f35bd3a482/jcm-09-02266-g004.jpg

相似文献

1
Narrow-Margin Excision for Invasive Acral Melanoma: Is It Acceptable?侵袭性肢端黑色素瘤的窄切缘切除:是否可接受?
J Clin Med. 2020 Jul 16;9(7):2266. doi: 10.3390/jcm9072266.
2
Surgical resection margin for T3-T4 primary acral melanoma: a multicenter retrospective cohort study.T3-T4 期原发性肢端黑色素瘤的手术切缘:一项多中心回顾性队列研究。
Arch Dermatol Res. 2023 Oct;315(8):2305-2312. doi: 10.1007/s00403-023-02609-2. Epub 2023 Mar 29.
3
Association of Excision Margin Size With Local Recurrence and Survival in Patients With T1a Melanoma at Critical Structures.临界结构 T1a 黑色素瘤患者切除边缘大小与局部复发和生存的关系。
JAMA Dermatol. 2023 Jun 1;159(6):587-595. doi: 10.1001/jamadermatol.2023.0620.
4
Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.高危原发性皮肤黑色素瘤广泛与窄切缘切除:一项随机试验的长期生存随访
Lancet Oncol. 2016 Feb;17(2):184-192. doi: 10.1016/S1470-2045(15)00482-9. Epub 2016 Jan 12.
5
Recurrence rate and survival implications of surgical margins in patients with acral melanoma. Is a wide margin necessary?肢端黑色素瘤患者手术切缘与复发率及生存率的相关性。是否需要广泛切缘?
Gac Med Mex. 2023;159(1):38-43. doi: 10.24875/GMM.M22000734.
6
Surgical excision margin for primary acral melanoma.原发性肢端黑色素瘤的手术切缘
J Surg Oncol. 2016 Dec;114(8):933-939. doi: 10.1002/jso.24442. Epub 2016 Sep 19.
7
Examining the role of wide excision margins in pediatric melanoma: A National Cancer Database analysis.
Pediatr Blood Cancer. 2022 Nov;69(11):e29884. doi: 10.1002/pbc.29884. Epub 2022 Aug 15.
8
Surgical management of primary cutaneous melanomas of the hands and feet.手足原发性皮肤黑色素瘤的外科治疗
Ann Surg. 1997 May;225(5):544-50; discussion 550-3. doi: 10.1097/00000658-199705000-00011.
9
Surgical margins for excision of primary cutaneous melanoma.原发性皮肤黑色素瘤切除的手术切缘
J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):422-9. doi: 10.1016/s0190-9622(97)70144-0.
10
Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.原发性皮肤黑色素瘤(厚度为1 - 2毫米)的最小安全病理切除切缘:对单中心治疗的2131例患者的分析
Ann Surg Oncol. 2016 Apr;23(4):1071-81. doi: 10.1245/s10434-015-4575-3. Epub 2015 May 9.

引用本文的文献

1
Nail Unit Melanoma: Uncommon Presentations to Keep in Mind.甲单位黑色素瘤:需牢记的不常见表现。
Skin Appendage Disord. 2024 Dec;10(6):536-539. doi: 10.1159/000539747. Epub 2024 Jul 15.
2
A Narrative Review of the Evolution of Diagnostic Techniques and Treatment Strategies for Acral Lentiginous Melanoma.肢端雀斑样黑素瘤的诊断技术和治疗策略的演变:叙述性回顾。
Int J Mol Sci. 2024 Sep 27;25(19):10414. doi: 10.3390/ijms251910414.
3
Current surgical management for melanoma.黑色素瘤的当前外科治疗方法。

本文引用的文献

1
Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival.肢端黑色素瘤中免疫组化BRAF V600E表达及肿瘤内BRAF V600E异质性:对黑色素瘤特异性生存的影响
J Clin Med. 2020 Mar 4;9(3):690. doi: 10.3390/jcm9030690.
2
Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.黑色素瘤预后:美国癌症联合委员会分期手册第八版的准确性。
J Natl Cancer Inst. 2020 Sep 1;112(9):921-928. doi: 10.1093/jnci/djaa008.
3
Intra- and Inter-Tumor Heterogeneity in Acral Melanoma: An Immunohistochemical Analysis.
J Dermatol. 2024 Mar;51(3):312-323. doi: 10.1111/1346-8138.17086. Epub 2023 Dec 27.
4
Nail Apparatus Melanoma: Current Management and Future Perspectives.甲襞黑色素瘤:当前治疗与未来展望
J Clin Med. 2023 Mar 12;12(6):2203. doi: 10.3390/jcm12062203.
肢端黑色素瘤的瘤内和瘤间异质性:免疫组织化学分析。
Int J Mol Sci. 2019 Dec 8;20(24):6191. doi: 10.3390/ijms20246191.
4
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities.黑色素瘤亚型:基因组特征、预后分子标志物和治疗可能性。
J Pathol. 2019 Apr;247(5):539-551. doi: 10.1002/path.5213. Epub 2019 Feb 15.
5
Melanoma and Immune Checkpoint Inhibitors.黑色素瘤与免疫检查点抑制剂。
Curr Oncol Rep. 2018 Mar 23;20(3):29. doi: 10.1007/s11912-018-0676-z.
6
Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.肢端雀斑样痣黑色素瘤与其他黑色素瘤:日本单中心分析
J Dermatol. 2017 Aug;44(8):932-938. doi: 10.1111/1346-8138.13834. Epub 2017 Mar 24.
7
Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation.原发性皮肤黑色素瘤的手术切除边缘:荟萃分析和贝叶斯概率评估。
Cancer Treat Rev. 2016 Jan;42:73-81. doi: 10.1016/j.ctrv.2015.10.013. Epub 2015 Nov 10.
8
Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?肢端黑色素瘤:谁受益于前哨淋巴结活检?
J Am Acad Dermatol. 2015 Jan;72(1):71-7. doi: 10.1016/j.jaad.2014.10.008. Epub 2014 Oct 28.
9
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
10
Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.前哨淋巴结的三重标记物聚合酶链反应检测作为黑色素瘤的预后因素
J Eur Acad Dermatol Venereol. 2015 May;29(5):912-8. doi: 10.1111/jdv.12722. Epub 2014 Sep 8.